Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures.
10.1038/cddis.2010.74
Crossref journal-article
Springer Science and Business Media LLC
Cell Death & Disease (297)
Bibliography

Sivananthan, S. N., Lee, A. W., Goodyer, C. G., & LeBlanc, A. C. (2010). Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures. Cell Death & Disease, 1(11), e100–e100.

Authors 4
  1. S N Sivananthan (first)
  2. A W Lee (additional)
  3. C G Goodyer (additional)
  4. A C LeBlanc (additional)
References 44 Referenced 41
  1. Albrecht S, Bogdanovic N, Ghetti B, Winblad B, LeBlanc AC . Caspase-6 activation in familial alzheimer disease brains carrying amyloid precursor protein or presenilin I or presenilin II mutations. J Neuropathol Exp Neurol 2009; 68: 1282–1293. (10.1097/NEN.0b013e3181c1da10) / J Neuropathol Exp Neurol by S Albrecht (2009)
  2. Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC . Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol 2007; 170: 1200–1209. (10.2353/ajpath.2007.060974) / Am J Pathol by S Albrecht (2007)
  3. Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC . Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease. Am J Pathol 2004; 165: 523–531. (10.1016/S0002-9440(10)63317-2) / Am J Pathol by H Guo (2004)
  4. Klaiman G, Petzke TL, Hammond J, LeBlanc AC . Targets of caspase-6 activity in human neurons and Alzheimer disease. Mol Cell Proteomics 2008; 7: 1541–1555. (10.1074/mcp.M800007-MCP200) / Mol Cell Proteomics by G Klaiman (2008)
  5. Bertram L, Tanzi RE . Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 2008; 9: 768–778. (10.1038/nrn2494) / Nat Rev Neurosci by L Bertram (2008)
  6. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A et al. APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy. Nat Genet 2006; 38: 24–26. (10.1038/ng1718) / Nat Genet by A Rovelet-Lecrux (2006)
  7. McPhie DL, Golde T, Eckman CB, Yager D, Brant JB, Neve RL . Beta-secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations. Brain Res Mol Brain Res 2001; 97: 103–113. (10.1016/S0169-328X(01)00294-7) / Brain Res Mol Brain Res by DL McPhie (2001)
  8. Giambarella U, Murayama Y, Ikezu T, Fujita T, Nishimoto I . Potential CRE suppression by familial Alzheimer's mutants of APP independent of adenylyl cyclase regulation. FEBS Lett 1997; 412: 97–101. (10.1016/S0014-5793(97)00753-9) / FEBS Lett by U Giambarella (1997)
  9. Yamatsuji T, Okamoto T, Takeda S, Murayama Y, Tanaka N, Nishimoto I . Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J 1996; 15: 498–509. (10.1002/j.1460-2075.1996.tb00382.x) / EMBO J by T Yamatsuji (1996)
  10. Eckert A, Steiner B, Marques C, Leutz S, Romig H, Haass C et al. Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation. J Neurosci Res 2001; 64: 183–192. (10.1002/jnr.1064) / J Neurosci Res by A Eckert (2001)
  11. Selkoe DJ, Podlisny MB . Deciphering the genetic basis of Alzheimer's disease. Annu Rev Genomics Hum Genet 2002; 3: 67–99. (10.1146/annurev.genom.3.022502.103022) / Annu Rev Genomics Hum Genet by DJ Selkoe (2002)
  12. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999; 97: 395–406. (10.1016/S0092-8674(00)80748-5) / Cell by FG Gervais (1999)
  13. LeBlanc A, Liu H, Goodyer C, Bergeron C, Hammond J . Caspase-6 role in apoptosis of human neurons, amyloidogenesis, and Alzheimer's disease. J Biol Chem 1999; 274: 23426–23436. (10.1074/jbc.274.33.23426) / J Biol Chem by A LeBlanc (1999)
  14. Srinivasula SM, Fernandes-Alnemri T, Zangrilli J, Robertson N, Armstrong RC, Wang L et al. The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32. J Biol Chem 1996; 271: 27099–27106. (10.1074/jbc.271.43.27099) / J Biol Chem by SM Srinivasula (1996)
  15. Klaiman G, Champagne N, LeBlanc AC . Self-activation of caspase-6 in vitro and in vivo: caspase-6 activation does not induce cell death in HEK293T cells. Biochim Biophys Acta 2009; 1793: 592–601. (10.1016/j.bbamcr.2008.12.004) / Biochim Biophys Acta by G Klaiman (2009)
  16. Kang JJ, Schaber MD, Srinivasula SM, Alnemri ES, Litwack G, Hall DJ et al. Cascades of mammalian caspase activation in the yeast Saccharomyces cerevisiae. J Biol Chem 1999; 274: 3189–3198. (10.1074/jbc.274.5.3189) / J Biol Chem by JJ Kang (1999)
  17. Allsopp TE, McLuckie J, Kerr LE, Macleod M, Sharkey J, Kelly JS . Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis. Cell Death Differ 2000; 7: 984–993. (10.1038/sj.cdd.4400733) / Cell Death Differ by TE Allsopp (2000)
  18. Doostzadeh-Cizeron J, Yin S, Goodrich DW . Apoptosis induced by the nuclear death domain protein p84N5 is associated with caspase-6 and NF-kappa B activation. J Biol Chem 2000; 275: 25336–25341. (10.1074/jbc.M000793200) / J Biol Chem by J Doostzadeh-Cizeron (2000)
  19. Cowling V, Downward J . Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain. Cell Death Differ 2002; 9: 1046–1056. (10.1038/sj.cdd.4401065) / Cell Death Differ by V Cowling (2002)
  20. Zhang Y, Goodyer C, LeBlanc A . Selective and protracted apoptosis in human primary neurons microinjected with active caspase-3, -6, -7, and -8. J Neurosci 2000; 20: 8384–8389. (10.1523/JNEUROSCI.20-22-08384.2000) / J Neurosci by Y Zhang (2000)
  21. Nikolaev A, McLaughlin T, O’Leary DD, Tessier-Lavigne M . APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 2009; 457: 981–989. (10.1038/nature07767) / Nature by A Nikolaev (2009)
  22. LeBlanc AC . The role of apoptotic pathways in Alzheimer's disease neurodegeneration and cell death. Curr Alzheimer Res 2005; 2: 389–402. (10.2174/156720505774330573) / Curr Alzheimer Res by AC LeBlanc (2005)
  23. van de Craen M, de Jonghe C, van den Brande I, Declercq W, van Gassen G, van Criekinge W et al. Identification of caspases that cleave presenilin-1 and presenilin-2. Five presenilin-1 (PS1) mutations do not alter the sensitivity of PS1 to caspases. FEBS Lett 1999; 445: 149–154. (10.1016/S0014-5793(99)00108-8) / FEBS Lett by M van de Craen (1999)
  24. Dickson DW . The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997; 56: 321–339. (10.1097/00005072-199704000-00001) / J Neuropathol Exp Neurol by DW Dickson (1997)
  25. Perry G, Kawai M, Tabaton M, Onorato M, Mulvihill P, Richey P et al. Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. J Neurosci 1991; 11: 1748–1755. (10.1523/JNEUROSCI.11-06-01748.1991) / J Neurosci by G Perry (1991)
  26. Stokin GB, Goldstein LS . Axonal transport and Alzheimer's disease. Annu Rev Biochem 2006; 75: 607–627. (10.1146/annurev.biochem.75.103004.142637) / Annu Rev Biochem by GB Stokin (2006)
  27. Salehi A, Delcroix JD, Belichenko PV, Zhan K, Wu C, Valletta JS et al. Increased APP expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron 2006; 51: 29–42. (10.1016/j.neuron.2006.05.022) / Neuron by A Salehi (2006)
  28. Wirths O, Weis J, Kayed R, Saido TC, Bayer TA . Age-dependent axonal degeneration in an Alzheimer mouse model. Neurobiol Aging 2007; 28: 1689–1699. (10.1016/j.neurobiolaging.2006.07.021) / Neurobiol Aging by O Wirths (2007)
  29. Nishimura I, Uetsuki T, Dani SU, Ohsawa Y, Saito I, Okamura H et al. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J Neurosci 1998; 18: 2387–2398. (10.1523/JNEUROSCI.18-07-02387.1998) / J Neurosci by I Nishimura (1998)
  30. Gotz J, Ittner LM, Kins S . Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? J Neurochem 2006; 98: 993–1006. (10.1111/j.1471-4159.2006.03955.x) / J Neurochem by J Gotz (2006)
  31. Lazarov O, Morfini GA, Lee EB, Farah MH, Szodorai A, DeBoer SR et al. Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci 2005; 25: 2386–2395. (10.1523/JNEUROSCI.3089-04.2005) / J Neurosci by O Lazarov (2005)
  32. Simon AM, Schiapparelli L, Salazar-Colocho P, Cuadrado-Tejedor M, Escribano L, Lopez de Maturana R et al. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels. Neurobiol Dis 2009; 33: 369–378. (10.1016/j.nbd.2008.11.005) / Neurobiol Dis by AM Simon (2009)
  33. Stokin GB, Almenar-Queralt A, Gunawardena S, Rodrigues EM, Falzone T, Kim J et al. Amyloid precursor protein-induced axonopathies are independent of amyloid-beta peptides. Hum Mol Genet 2008; 17: 3474–3486. (10.1093/hmg/ddn240) / Hum Mol Genet by GB Stokin (2008)
  34. Citron M, Teplow DB, Selkoe DJ . Generation of amyloid beta protein from its precursor is sequence specific. Neuron 1995; 14: 661–670. (10.1016/0896-6273(95)90323-2) / Neuron by M Citron (1995)
  35. Paradis E, Douillard H, Koutroumanis M, Goodyer C, LeBlanc A . Amyloid ßpeptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J Neurosci 1996; 16: 7533–7539. (10.1523/JNEUROSCI.16-23-07533.1996) / J Neurosci by E Paradis (1996)
  36. LeBlanc A . Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J Neurosci 1995; 15: 7837–7846. (10.1523/JNEUROSCI.15-12-07837.1995) / J Neurosci by A LeBlanc (1995)
  37. Esposito L, Gan L, Yu GQ, Essrich C, Mucke L . Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells. J Neurochem 2004; 91: 1260–1274. (10.1111/j.1471-4159.2004.02816.x) / J Neurochem by L Esposito (2004)
  38. Luo JJ, Wallace W, Riccioni T, Ingram DK, Roth GS, Kusiak JW . Death of PC12 cells and hippocampal neurons induced by adenoviral-mediated FAD human amyloid precursor protein gene expression. J Neurosci Res 1999; 55: 629–642. (10.1002/(SICI)1097-4547(19990301)55:5<629::AID-JNR10>3.0.CO;2-Y) / J Neurosci Res by JJ Luo (1999)
  39. Zhao B, Chrest FJ, Horton Jr WE, Sisodia SS, Kusiak JW . Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J Neurosci Res 1997; 47: 253–263. (10.1002/(SICI)1097-4547(19970201)47:3<253::AID-JNR3>3.0.CO;2-H) / J Neurosci Res by B Zhao (1997)
  40. Small SA, Duff K . Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis. Neuron 2008; 60: 534–542. (10.1016/j.neuron.2008.11.007) / Neuron by SA Small (2008)
  41. Gomez-Isla T, Hollister R, West H, Mui S, Growdon J, Petersen R et al. Neuronal loss correlated with but exceeds neurofibrillary tangles in Alzheimer′s disease. Ann Neurol 1996; 41: 17–24. (10.1002/ana.410410106) / Ann Neurol by T Gomez-Isla (1996)
  42. Oyama F, Kotliarova S, Harada A, Ito M, Miyazaki H, Ueyama Y et al. Gem GTPase and tau: morphological changes induced by gem GTPase in CHO cells are antagonized by tau. J Biol Chem 2004; 279: 27272–27277. (10.1074/jbc.M401634200) / J Biol Chem by F Oyama (2004)
  43. Bergink S, Severijnen LA, Wijgers N, Sugasawa K, Yousaf H, Kros JM et al. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair. Neurobiol Dis 2006; 23: 708–716. (10.1016/j.nbd.2006.06.005) / Neurobiol Dis by S Bergink (2006)
  44. Zhang Y, McLaughlin R, Goodyer C, LeBlanc A . Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neurons. J Cell Biol 2002; 156: 519–529. (10.1083/jcb.200110119) / J Cell Biol by Y Zhang (2002)
Dates
Type When
Created 14 years, 9 months ago (Nov. 18, 2010, 9:44 a.m.)
Deposited 2 years, 7 months ago (Jan. 5, 2023, 7:16 p.m.)
Indexed 3 weeks, 1 day ago (Aug. 6, 2025, 9:10 a.m.)
Issued 14 years, 9 months ago (Nov. 18, 2010)
Published 14 years, 9 months ago (Nov. 18, 2010)
Published Online 14 years, 9 months ago (Nov. 18, 2010)
Funders 0

None

@article{Sivananthan_2010, title={Familial amyloid precursor protein mutants cause caspase-6-dependent but amyloid β-peptide-independent neuronal degeneration in primary human neuron cultures.}, volume={1}, ISSN={2041-4889}, url={http://dx.doi.org/10.1038/cddis.2010.74}, DOI={10.1038/cddis.2010.74}, number={11}, journal={Cell Death &amp; Disease}, publisher={Springer Science and Business Media LLC}, author={Sivananthan, S N and Lee, A W and Goodyer, C G and LeBlanc, A C}, year={2010}, month=nov, pages={e100–e100} }